ACNB vs BIIB · P/E 11, rev $103.0M vs P/E 21, rev $9.89B
ACNB Corporation (ACNB) versus Biogen Inc (BIIB) — a side-by-side from cached financials, not a winner call.
ACNB Corporation (ACNB) is a banks - regional company listed on NASDAQ.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Latest reported ACNB revenue for 2026-06-30 was $103.0M. Net income was $28.9M. ACNB currently screens at market cap $573.6M and trailing P/E 11.3.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
ACNB currently screens at market cap $573.6M and trailing P/E 11.3. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the ACNB and BIIB stock pages for the full models.
Not investment advice.